• Kym Baker

    General Manager
    Patheon, part of Thermo Fisher Scientific
    Patheon Biologics Australia Pty Ltd
    "Manufacturing modern miracles"
  • Keith Chappell

    Senior Research Fellow
    The University of Queensland
    "Rapid response pipeline for stabilised subunit vaccines"
  • Henry Chiou

    Director of Product Management, Protein Expression & Transfection
    Thermo Fisher Scientific
    "Streamlining biologics development with the Expi systems"
  • David Craik

    ARC Laureate Fellow
    The University of Queensland
    "Natural peptide-based scaffolds in drug design"
  • Craig Franklin

    Deputy Head of School & Professor School of Biological Sciences
    The University of Queensland
    "Why biodiversity is important - insights from extreme life: an Australian perspective"
  • Anton Glieder

    Professor in Biotechnology
    Graz University of Technology
  • Gaurav Gupta

    Senior Research Scientist
    University of Oxford
    "VLPs as carrier for potential vaccine candidates"
  • Catherine Owczarek

    Director, Recombinant Proteins
    CSL Limited
    "Recombinant Protein Expression in Mammalian Cells: Bridging the gap between research and development"
  • Bernd Rehm

    Professor and Director of Centre for Cell Factories and Biopolymers
    Griffith University
    "In vivo assembled polyester scaffolds for protein production"
  • Derek Richard

    Professor and Scientific Director of Cancer & Ageing Research Program
    Queensland University of Technology
    "Understanding the role of DNA repair in disease and ageing"
  • Anne Skaja Robinson

    Professor and Head of Chemical Engineering
    Carnegie Mellon University
    "Control of glycosylation in antibody expression in CHO cells"
  • Jason Ryan

    Head, Upstream Bioprocessing
    Luina Bio
    "Bacterial and yeast recombinant protein production – An industrial perspective"
  • Sabine Suppmann

    Head Protein Production
    Max Planck Institute of Biochemistry
    "A Protein Production Core Facility - the Good, the Bad and the Ugly"
  • Ross Wilson

    Principal Investigator
    Berkeley University of California
    "Engineering CRISPR-Cas9 for cell-targeted therapeutic genome editing"